These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 1797456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
    Chin NX, Neu HC.
    Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.
    Chin NX, Gu JW, Fang W, Neu HC.
    Diagn Microbiol Infect Dis; 1992 May; 15(4):331-7. PubMed ID: 1611848
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.
    Chin NX, Gu JW, Fang W, Neu HC.
    Antimicrob Agents Chemother; 1991 Feb; 35(2):259-66. PubMed ID: 2024959
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
    Neu HC.
    Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC, Chin NX, Neu NM.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of Ro 09-1428 compared to other cephalosporins.
    Chin NX, Gu JW, Fang W, Neu HC.
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):669-75. PubMed ID: 1748124
    [Abstract] [Full Text] [Related]

  • 12. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
    Johnson DM, Jones RN.
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):181-8. PubMed ID: 1396735
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
    Martínez-Beltrán J, Cantón R, Liñares J, García de Lomas J, Gimeno C, Tubau F, Baquero F.
    Eur J Clin Microbiol Infect Dis; 1995 Mar; 14(3):244-52. PubMed ID: 7614970
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.
    Briggs BM, Jones RN, Erwin ME, Barrett MS, Johnson DM.
    Diagn Microbiol Infect Dis; 1991 Mar; 14(5):425-34. PubMed ID: 1797457
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro activity and beta-lactamase stability of LJC 10,627.
    Neu HC, Gu JW, Fang W, Chin NX.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1418-23. PubMed ID: 1510436
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.